• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MENTOR BREAST IMPLANT SILICONE GEL, SMOOTH RND MODERATE PLUS PROFILE; BREAST IMPLANTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MENTOR BREAST IMPLANT SILICONE GEL, SMOOTH RND MODERATE PLUS PROFILE; BREAST IMPLANTS Back to Search Results
Catalog Number 350-2501BC
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Raynauds Phenomenon (2034); Swelling (2091); Ulcer (2274); Urticaria (2278); Impaired Healing (2378)
Date of Event 12/04/2013
Type of Reportable Event Serious Injury
Event or Problem Description
After getting breast implant in (b)(6) 2013, i had hives that lasted a year.In 2014 i started to get swelling in my fingers and toes.The swelling comes and goes.I developed raynaud's syndrome, and symptoms that look like rheumatoid arthritis, but a rheumatologist tested my blood and it was negative for this condition.I have ulcers on my fingers that will not heal.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BREAST IMPLANT SILICONE GEL, SMOOTH RND MODERATE PLUS PROFILE
Common Device Name
BREAST IMPLANTS
Manufacturer (Section D)
MENTOR
MDR Report Key6237669
Report NumberMW5067145
Device Sequence Number16582197
Product Code FTR
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2013
Reporter Type Voluntary
Type of Report Initial
Report Date (Section B) 01/09/2017
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device No Information
Device Catalogue Number350-2501BC
Device Lot Number6766471
Was Device Available for Evaluation? Yes
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date01/09/2017
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
CYMBALTA 30MG DAILY; FISH OIL; MULTI VITAMIN ; ORTHO MICRONOR DAILY
Outcome Attributed to Adverse Event Disability;
Patient Age40 YR
Patient Weight52
-
-